Tanida · Nihon rinsho. Japanese journal of clinical medicine 1997 · narrative review · n=3 studies

[Critical review on the WHO/IARC report regarding carcinogenicity of Helicobacter pylori].

Cited 2 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of epidemiological and experimental evidence with no new human data.

PubMed 9103907 · record verified 2026-08-30

What was done

The author reviewed the 1994 WHO/IARC report that designated Helicobacter pylori as a definite human carcinogen, assessing histological pathways, pooled prospective epidemiological studies, and available experimental evidence for gastric carcinogenesis.

What was found

The review notes that H. pylori causes histological gastritis and that long-lasting infection may induce atrophic gastritis along the gastritis-metaplasia-carcinoma sequence. In a cited pooled analysis of three prospective epidemiological studies, the relative risk for developing gastric cancer with H. pylori infection was 3.8 (statistically significant). However, the abstract reports that experimental evidence for carcinogenicity was lacking.

Why it matters

It outlines the prospective epidemiological evidence used to classify H. pylori as a group 1 carcinogen while noting the absence of experimental animal confirmation at the time of the monograph.

Limits

This is a narrative review rather than a systematic review. The abstract does not report participant sample sizes, confidence intervals, search methodology, or details on confounding control across the cited prospective studies.

Cited by